Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nephrol Dial Transplant
Main Authors: Bhandari, Sunil, Ives, Natalie, Brettell, Elizabeth A., Valente, Marie, Cockwell, Paul, Topham, Peter S., Cleland, John G., Khwaja, Arif, El Nahas, Meguid
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2016
Assuntos:
CLINICAL SCIENCE
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://ncbi.nlm.nih.gov/pubmed/26429974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv346
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares